1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia Pacific PCR for Respiratory Infection Diagnostics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia Pacific PCR for Respiratory Infection Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia Pacific PCR for Respiratory Infection Diagnostics Market Regional Analysis
6.2 Asia Pacific PCR for Respiratory Infection Diagnostics Market Revenue 2019-2028 (US$ Million)
6.3 Asia Pacific PCR for Respiratory Infection Diagnostics Market Forecast Analysis
7. Asia Pacific PCR for Respiratory Infection Diagnostics Market Analysis – by Type
7.1 Real-Time PCR
- 7.1.1 Overview
- 7.1.2 Real-Time PCR: Asia Pacific PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Multiplex PCR
- 7.2.1 Overview
- 7.2.2 Multiplex PCR: Asia Pacific PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Traditional PCR
- 7.3.1 Overview
- 7.3.2 Traditional PCR: Asia Pacific PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Digital PCR
- 7.4.1 Overview
- 7.4.2 Digital PCR: Asia Pacific PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.5 Reverse-Transcriptase
- 7.5.1 Overview
- 7.5.2 Reverse-Transcriptase: Asia Pacific PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: Asia Pacific PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Asia Pacific PCR for Respiratory Infection Diagnostics Market Analysis – by Product Type
8.1 Reagents & Kits
- 8.1.1 Overview
- 8.1.2 Reagents & Kits: Asia Pacific PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Instruments
- 8.2.1 Overview
- 8.2.2 Instruments: Asia Pacific PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Asia Pacific PCR for Respiratory Infection Diagnostics Market Analysis – by Infection Type
9.1 Bacterial Infections
- 9.1.1 Overview
- 9.1.2 Bacterial Infections: Asia Pacific PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Viral Infections
- 9.2.1 Overview
- 9.2.2 Viral Infections: Asia Pacific PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Fungal & Other Pathogens
- 9.3.1 Overview
- 9.3.2 Fungal & Other Pathogens: Asia Pacific PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. Asia Pacific PCR for Respiratory Infection Diagnostics Market Analysis – by End User
10.1 Hospitals
- 10.1.1 Overview
- 10.1.2 Hospitals: Asia Pacific PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.2 Physician Clinics
- 10.2.1 Overview
- 10.2.2 Physician Clinics: Asia Pacific PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.3 Clinical Laboratories
- 10.3.1 Overview
- 10.3.2 Clinical Laboratories: Asia Pacific PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.4 Academic & Research Institutions
- 10.4.1 Overview
- 10.4.2 Academic & Research Institutions: Asia Pacific PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.5 Biotech & Pharma Companies
- 10.5.1 Overview
- 10.5.2 Biotech & Pharma Companies: Asia Pacific PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
11. Asia Pacific PCR for Respiratory Infection Diagnostics Market – Asia-Pacific Analysis
11.1 Overview
11.2 Asia-Pacific
- 11.2.1 Asia Pacific PCR for Respiratory Infection Diagnostics Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 11.2.1.1 Asia Pacific PCR for Respiratory Infection Diagnostics Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 China:
Asia Pacific PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.1.1 China: Asia Pacific PCR for Respiratory Infection Diagnostics Market Breakdown, by Type
- 11.2.1.1.2 China: Asia Pacific PCR for Respiratory Infection Diagnostics Market Breakdown, by Product Type
- 11.2.1.1.3 China: Asia Pacific PCR for Respiratory Infection Diagnostics Market Breakdown, by Infection Type
- 11.2.1.1.4 China: Asia Pacific PCR for Respiratory Infection Diagnostics Market Breakdown, by End User
- 11.2.1.2 India:
Asia Pacific PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.2.1 India: Asia Pacific PCR for Respiratory Infection Diagnostics Market Breakdown, by Type
- 11.2.1.2.2 India: Asia Pacific PCR for Respiratory Infection Diagnostics Market Breakdown, by Product Type
- 11.2.1.2.3 India: Asia Pacific PCR for Respiratory Infection Diagnostics Market Breakdown, by Infection Type
- 11.2.1.2.4 India: Asia Pacific PCR for Respiratory Infection Diagnostics Market Breakdown, by End User
- 11.2.1.3 Japan:
Asia Pacific PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.3.1 Japan: Asia Pacific PCR for Respiratory Infection Diagnostics Market Breakdown, by Type
- 11.2.1.3.2 Japan: Asia Pacific PCR for Respiratory Infection Diagnostics Market Breakdown, by Product Type
- 11.2.1.3.3 Japan: Asia Pacific PCR for Respiratory Infection Diagnostics Market Breakdown, by Infection Type
- 11.2.1.3.4 Japan: Asia Pacific PCR for Respiratory Infection Diagnostics Market Breakdown, by End User
- 11.2.1.4 Australia:
Asia Pacific PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.4.1 Australia: Asia Pacific PCR for Respiratory Infection Diagnostics Market Breakdown, by Type
- 11.2.1.4.2 Australia: Asia Pacific PCR for Respiratory Infection Diagnostics Market Breakdown, by Product Type
- 11.2.1.4.3 Australia: Asia Pacific PCR for Respiratory Infection Diagnostics Market Breakdown, by Infection Type
- 11.2.1.4.4 Australia: Asia Pacific PCR for Respiratory Infection Diagnostics Market Breakdown, by End User
- 11.2.1.5 Rest of Asia-Pacific :
Asia Pacific PCR for Respiratory Infection Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.5.1 Rest of Asia-Pacific : Asia Pacific PCR for Respiratory Infection Diagnostics Market Breakdown, by Type
- 11.2.1.5.2 Rest of Asia-Pacific : Asia Pacific PCR for Respiratory Infection Diagnostics Market Breakdown, by Product Type
- 11.2.1.5.3 Rest of Asia-Pacific : Asia Pacific PCR for Respiratory Infection Diagnostics Market Breakdown, by Infection Type
- 11.2.1.5.4 Rest of Asia-Pacific : Asia Pacific PCR for Respiratory Infection Diagnostics Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Abbott
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 F. HOFFMANN-LA ROCHE LTD
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Hologic, Inc.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 BD
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 BIO-RAD LABORATORIES INC.
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 bioMerieux SA
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 QIAGEN
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Thermo Fisher Scientific Inc.
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Seegene Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations